Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases

Liver transplant (LT) recipients or other immunocompromised patients were not included in the registration trials studying the efficacy of vaccines against SARS-CoV-2. Although the clinical efficacy of COVID-19 vaccines in immunocompromised patients is unknown, many societies have recommended vaccination of this highly vulnerable patient population.In this prospective study, we determined antibody responses to spike protein, 4 weeks after the...